D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 93 Citations 23,521 285 World Ranking 5088 National Ranking 229

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His main research concerns Nanomedicine, Drug delivery, Targeted drug delivery, Pharmacology and Drug. His Nanomedicine study is concerned with the field of Nanotechnology as a whole. His research integrates issues of Tumor targeting, Nanoparticle, Computational biology and Biodistribution in his study of Drug delivery.

His Targeted drug delivery research incorporates themes from Pharmaceutical sciences, Biophysics, Micelle and Therapeutic index. His Pharmacology study integrates concerns from other disciplines, such as Cancer cell, Cancer research and In vitro. His Drug research focuses on Combination therapy and how it relates to Cancer and Tumor targeted.

His most cited work include:

  • Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress (871 citations)
  • Challenges and strategies in anti-cancer nanomedicine development: An industry perspective ☆ (493 citations)
  • Challenges and strategies in anti-cancer nanomedicine development: An industry perspective ☆ (493 citations)

What are the main themes of his work throughout his whole career to date?

Twan Lammers focuses on Drug delivery, Nanomedicine, Pharmacology, Targeted drug delivery and Cancer research. His research in Drug delivery intersects with topics in Biomedical engineering, Microbubbles and Biodistribution. His Nanomedicine study incorporates themes from Cancer, Combination therapy, Tumor targeting and Intensive care medicine.

His Pharmacology study combines topics in areas such as In vitro, Liposome and Doxorubicin. His Targeted drug delivery study also includes

  • Micelle that intertwine with fields like Polymer,
  • Biophysics together with Ex vivo. As a part of the same scientific family, Twan Lammers mostly works in the field of Cancer research, focusing on Macrophage and, on occasion, Inflammation.

He most often published in these fields:

  • Drug delivery (74.77%)
  • Nanomedicine (66.82%)
  • Pharmacology (50.47%)

What were the highlights of his more recent work (between 2019-2021)?

  • Nanomedicine (66.82%)
  • Drug delivery (74.77%)
  • Cancer (18.46%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Nanomedicine, Drug delivery, Cancer, Cancer research and Immune system. Twan Lammers incorporates Nanomedicine and In patient in his research. He interconnects Microbubbles, Chemical engineering, Drug and Internalization in the investigation of issues within Drug delivery.

His study on Drug is covered under Pharmacology. The concepts of his Cancer study are interwoven with issues in Nanocarriers, Oncology and Biodistribution. In his work, Chemotherapy and Advanced stage is strongly intertwined with Tumor microenvironment, which is a subfield of Cancer research.

Between 2019 and 2021, his most popular works were:

  • The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. (41 citations)
  • The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. (41 citations)
  • The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. (41 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

His scientific interests lie mostly in Nanomedicine, Drug delivery, Treatment efficacy, Drug and Biomedical engineering. His Nanomedicine research integrates issues from Clinical study design, Risk analysis and Engineering ethics. His study in the field of Nanocarriers is also linked to topics like In patient.

His study in Treatment efficacy is interdisciplinary in nature, drawing from both Immune system, Dexamethasone, Coronavirus disease 2019, Corticosteroid and Pharmacology. His studies in Drug integrate themes in fields like Cancer immunotherapy, Tumor targeting and Intensive care medicine. His biological study spans a wide range of topics, including Magnetic particle imaging, Blood–brain barrier, Magnetic resonance imaging, Hyperthermia and Dynamic light scattering.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

Twan Gerardus Gertudis Maria Lammers;F. Kiessling;W.E. Hennink;Gerrit Storm;Gerrit Storm.
Journal of Controlled Release (2012)

1115 Citations

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective ☆

Jennifer I. Hare;Twan Lammers;Twan Lammers;Marianne B. Ashford;Sanyogitta Puri.
Advanced Drug Delivery Reviews (2017)

653 Citations

Tumour-targeted nanomedicines: principles and practice.

T.G.G.M. Lammers;W.E. Hennink;G. Storm.
British Journal of Cancer (2008)

585 Citations

Tumor targeting via EPR: Strategies to enhance patient responses

Susanne K. Golombek;Jan Niklas May;Benjamin Theek;Lia Appold.
Advanced Drug Delivery Reviews (2018)

442 Citations

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner

Chunfu Zhang;Manfred Jugold;Eva C. Woenne;Twan Lammers.
Cancer Research (2007)

409 Citations

Nanotheranostics and image-guided drug delivery: current concepts and future directions.

Twan Lammers;Fabian Kiessling;Wim E. Hennink;Gert Storm.
Molecular Pharmaceutics (2010)

389 Citations

Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation

Marina Talelli;Matthias Barz;Cristianne J.F. Rijcken;Fabian Kiessling.
Nano Today (2015)

341 Citations

Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics

F. Kiessling;S. Fokong;P. Koczera;W. Lederle.
The Journal of Nuclear Medicine (2012)

310 Citations

Noninvasive Imaging of Nanomedicines and Nanotheranostics : Principles, Progress, and Prospects

Sijumon Kunjachan;Josef Ehling;Gert Storm;Fabian Kiessling.
Chemical Reviews (2015)

304 Citations

Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines

Sijumon Kunjachan;Robert Pola;Felix Gremse;Benjamin Theek.
Nano Letters (2014)

300 Citations

Best Scientists Citing Twan Lammers

Wim E. Hennink

Wim E. Hennink

Utrecht University

Publications: 53

Fabian Kiessling

Fabian Kiessling

RWTH Aachen University

Publications: 52

Zhiyuan Zhong

Zhiyuan Zhong

Soochow University

Publications: 52

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 47

Fenghua Meng

Fenghua Meng

Soochow University

Publications: 44

Gert Storm

Gert Storm

Utrecht University

Publications: 43

Chao Deng

Chao Deng

Soochow University

Publications: 32

Frank Tacke

Frank Tacke

Charité - University Medicine Berlin

Publications: 31

Karel Ulbrich

Karel Ulbrich

Czech Academy of Sciences

Publications: 28

Christian Weber

Christian Weber

Ludwig Maximilian University of Munich

Publications: 24

Rudolf Zentel

Rudolf Zentel

Johannes Gutenberg University of Mainz

Publications: 24

Zhongwei Gu

Zhongwei Gu

Sichuan University

Publications: 23

Xuesi Chen

Xuesi Chen

Chinese Academy of Sciences

Publications: 23

Vladimir P. Torchilin

Vladimir P. Torchilin

Northeastern University

Publications: 22

Ick Chan Kwon

Ick Chan Kwon

Korea Institute of Science and Technology

Publications: 22

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.